Treatment Rationale and Design of a Phase III Study of Afatinib or Chemotherapy in Patients with Non–small-cell Lung Cancer Harboring Sensitizing Uncommon Epidermal Growth Factor Receptor Mutations (ACHILLES/TORG1834)

Satoru Miura, Takeharu Yamanaka, Terufumi Kato, Satoshi Ikeda, Hidehito Horinouchi, Eiki Ichihara, Masaki Kanazu, Yuichi Takiguchi, Kentaro Tanaka, Yasuhiro Goto, Masafumi Sata, Koichi Hagiwara, Hiroaki Okamoto, Hiroshi Tanaka

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint Dive into the research topics of 'Treatment Rationale and Design of a Phase III Study of Afatinib or Chemotherapy in Patients with Non–small-cell Lung Cancer Harboring Sensitizing Uncommon Epidermal Growth Factor Receptor Mutations (ACHILLES/TORG1834)'. Together they form a unique fingerprint.

Medicine & Life Sciences